TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects

Abstract excerpt

There is growing evidence that germline mutations in certain genes influence cancer susceptibility, tumor evolution, as well as clinical outcomes. Identification of a disease-causing genetic variant enables testing and diagnosis of at-risk individuals. For breast cancer, several genes such as BRCA1, BRCA2, PALB2, ATM, and CHEK2 act as high- to moderate-penetrance cancer susceptibility genes. Genotyping of these...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clusterin in disease pathology
• Share to Genetic factors in colorectal cancer
• Share to TGF-β signaling in diseases